Michel Lagarde - Oct 5, 2023 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
Director
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Oct 5, 2023
Transactions value $
$0
Form type
4
Date filed
10/10/2023, 04:44 PM
Previous filing
Aug 29, 2023
Next filing
Feb 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock +Grant/Award $0 +1,132 $0.00 1,132 Oct 5, 2023 Direct F1

Explanation of Responses:

Id Content
F1 Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.